id	sid	eid	entity	type
dti-1422	1	1	13drug	CARDINAL
dti-1422	1	2	ueda1	PRODUCT
dti-1422	1	3	hiroki ishii1	PERSON
dti-1422	1	4	taisuke kitano1	PERSON
dti-1422	1	5	shindo1	PERSON
dti-1422	1	6	kiyonori ito1	ORG
dti-1422	1	7	keiji hirai1	PERSON
dti-1422	1	8	honami mori1	PERSON
dti-1422	1	9	hoshino1	PRODUCT
dti-1422	1	10	susumu ookawara1	PERSON
dti-1422	1	11	kaoru tabei3	PERSON
dti-1422	1	12	2division	CARDINAL
dti-1422	1	13	saitama medical center	ORG
dti-1422	1	14	saitama	GPE
dti-1422	1	15	japan	GPE
dti-1422	2	1	3minamiuonuma	CARDINAL
dti-1422	2	2	niigata	GPE
dti-1422	2	3	japan	GPE
dti-1422	4	1	twenty	CARDINAL
dti-1422	4	2	24.5 ± 13.4 ml	QUANTITY
dti-1422	4	3	5 mg	QUANTITY
dti-1422	4	4	52 weeks	DATE
dti-1422	6	1	linagliptin	PERSON
dti-1422	6	2	7.32 ± 0.77%	MONEY
dti-1422	6	3	6.85 ± 0.87%	MONEY
dti-1422	6	4	0.05	CARDINAL
dti-1422	6	5	189.6 ±	MONEY
dti-1422	6	6	49.0	CARDINAL
dti-1422	6	7	170.2 ±	MONEY
dti-1422	6	8	0.05	CARDINAL
dti-1422	6	9	107.1 ±	MONEY
dti-1422	6	10	90.2 ± 31.0 mg	QUANTITY
dti-1422	6	11	0.05	CARDINAL
dti-1422	7	1	annual	DATE
dti-1422	9	1	linagliptin	PERSON
dti-1422	10	1	linagliptin	PERSON
dti-1422	12	1	may 25,	DATE
dti-1422	12	2	2016	DATE
dti-1422	13	1	august 11, 2016	DATE
dti-1422	14	1	august 15, 2016	DATE
dti-1422	15	1	anuj chauhan	PERSON
dti-1422	15	2	five	CARDINAL
dti-1422	16	1	910	CARDINAL
dti-1422	20	1	3.0	CARDINAL
dti-1422	24	1	third	ORDINAL
dti-1422	30	1	first	ORDINAL
dti-1422	32	1	dipeptidyl peptidase-4	PERSON
dti-1422	32	2	2016	CARDINAL
dti-1422	32	3	10	CARDINAL
dti-1422	32	4	http://www.la-press.com/drug-target-insights-journal-j23	CARDINAL
dti-1422	32	5	http://creativecommons.org/licenses/by-nc/3.0/ http://creativecommons.org/licenses/by-nc/3.0/	TIME
dti-1422	32	6	mailto:ymori@jichi.ac.jp http://www.la-press.com http://www.la-press.com/drug-target-insights-journal-j23	PERSON
dti-1422	32	7	al 14	ORG
dti-1422	35	1	helsinki	ORG
dti-1422	35	2	the ethics committee of	ORG
dti-1422	35	3	saitama medical center	ORG
dti-1422	35	4	jichi medical university	ORG
dti-1422	38	1	between march 2013	DATE
dti-1422	38	2	july 2014	DATE
dti-1422	38	3	30	CARDINAL
dti-1422	39	1	2	CARDINAL
dti-1422	39	2	60	MONEY
dti-1422	40	1	0.15	CARDINAL
dti-1422	41	1	1	CARDINAL
dti-1422	41	2	linagliptin	CARDINAL
dti-1422	43	1	1	CARDINAL
dti-1422	44	1	52-week	DATE
dti-1422	45	1	linagliptin 5 mg	DATE
dti-1422	45	2	the morning	TIME
dti-1422	46	1	six	CARDINAL
dti-1422	46	2	5 mg	QUANTITY
dti-1422	49	1	ldl)-cholesterol	ORG
dti-1422	49	2	hdl)-cholesterol	ORG
dti-1422	49	3	12	CARDINAL
dti-1422	49	4	24	DATE
dti-1422	49	5	38	DATE
dti-1422	49	6	52 weeks	DATE
dti-1422	49	7	linagliptin	CARDINAL
dti-1422	51	1	annual	DATE
dti-1422	54	1	egfr	PERSON
dti-1422	54	2	japanese	NORP
dti-1422	55	1	194	CARDINAL
dti-1422	55	2	0.739	CARDINAL
dti-1422	55	3	saitama medical center	ORG
dti-1422	55	4	jichi medical university	ORG
dti-1422	57	1	±	CARDINAL
dti-1422	59	1	0.05	CARDINAL
dti-1422	60	1	annual	DATE
dti-1422	60	2	linagliptin	CARDINAL
dti-1422	61	1	thirty	CARDINAL
dti-1422	61	2	linagliptin	DATE
dti-1422	62	1	2	CARDINAL
dti-1422	63	1	four	CARDINAL
dti-1422	63	2	1	CARDINAL
dti-1422	64	1	hdl	ORG
dti-1422	66	1	15drug	CARDINAL
dti-1422	67	1	two	CARDINAL
dti-1422	68	1	one	CARDINAL
dti-1422	69	1	three	CARDINAL
dti-1422	70	1	twenty	CARDINAL
dti-1422	71	1	2	CARDINAL
dti-1422	72	1	1	CARDINAL
dti-1422	74	1	linagliptin	PERSON
dti-1422	74	2	3	CARDINAL
dti-1422	74	3	2	CARDINAL
dti-1422	76	1	linagliptin	PERSON
dti-1422	76	2	4	CARDINAL
dti-1422	76	3	2	CARDINAL
dti-1422	76	4	4	CARDINAL
dti-1422	76	5	2	CARDINAL
dti-1422	76	6	annual	DATE
dti-1422	76	7	5	CARDINAL
dti-1422	76	8	2	CARDINAL
dti-1422	78	1	linagliptin	CARDINAL
dti-1422	78	2	2	CARDINAL
dti-1422	81	1	linagliptin administration	PERSON
dti-1422	81	2	annual	DATE
dti-1422	83	1	linagliptin	PERSON
dti-1422	89	1	2	CARDINAL
dti-1422	89	2	patient flowchart	ORG
dti-1422	90	1	1	CARDINAL
dti-1422	92	1	20 age (years	DATE
dti-1422	92	2	69.7 ±	CARDINAL
dti-1422	92	3	12.9	CARDINAL
dti-1422	92	4	14/6	CARDINAL
dti-1422	92	5	3 5	CARDINAL
dti-1422	92	6	4 9	DATE
dti-1422	92	7	5 6	CARDINAL
dti-1422	92	8	5	CARDINAL
dti-1422	92	9	20	CARDINAL
dti-1422	92	10	3	CARDINAL
dti-1422	92	11	2	CARDINAL
dti-1422	92	12	1	CARDINAL
dti-1422	92	13	6	CARDINAL
dti-1422	92	14	4	CARDINAL
dti-1422	92	15	10	CARDINAL
dti-1422	92	16	11	CARDINAL
dti-1422	92	17	1 fenofibrate 1	QUANTITY
dti-1422	92	18	angiotensin ii-receptor	PERSON
dti-1422	93	1	ueda et al 16	PERSON
dti-1422	94	1	24-week	DATE
dti-1422	94	2	1-year	DATE
dti-1422	94	3	52 weeks	DATE
dti-1422	95	1	3	CARDINAL
dti-1422	95	2	20	CARDINAL
dti-1422	97	1	0.05	CARDINAL
dti-1422	99	1	2	CARDINAL
dti-1422	99	2	linagliptin administration	ORG
dti-1422	100	1	52 weeks	DATE
dti-1422	100	2	linagliptin administration statistics sbp	ORG
dti-1422	100	3	141.1 ±	CARDINAL
dti-1422	100	4	144.4	CARDINAL
dti-1422	100	5	19.8 ns dbp	PERSON
dti-1422	100	6	72.5 ±	CARDINAL
dti-1422	100	7	14.4 ns	QUANTITY
dti-1422	100	8	78.1 ±	MONEY
dti-1422	100	9	11.0 ns	QUANTITY
dti-1422	100	10	2.5	CARDINAL
dti-1422	100	11	(ml/min/1.73 m2	QUANTITY
dti-1422	100	12	24.5	CARDINAL
dti-1422	100	13	13.0	CARDINAL
dti-1422	100	14	annual	DATE
dti-1422	100	15	(ml/min/1.73 m2	QUANTITY
dti-1422	100	16	± 14.2 -4.0	QUANTITY
dti-1422	100	17	± 3.8 ns	QUANTITY
dti-1422	102	1	2.2 ± 2.6 1.9 ± 2.4	MONEY
dti-1422	102	2	7.3	CARDINAL
dti-1422	102	3	162.2	CARDINAL
dti-1422	102	4	158.7	CARDINAL
dti-1422	102	5	64.6 ns	QUANTITY
dti-1422	102	6	189.6	CARDINAL
dti-1422	102	7	107.1	CARDINAL
dti-1422	102	8	40.8 ±	CARDINAL
dti-1422	102	9	43.6 ± 12.1 ns	QUANTITY
dti-1422	102	10	225.7	CARDINAL
dti-1422	102	11	208.4	CARDINAL
dti-1422	102	12	6.9	CARDINAL
dti-1422	102	13	0.5 ns albumin	QUANTITY
dti-1422	102	14	3.8 ±	MONEY
dti-1422	102	15	0.5 ns	QUANTITY
dti-1422	102	16	139.0 ±	MONEY
dti-1422	102	17	139.5 ± 2.9	QUANTITY
dti-1422	102	18	4.6	CARDINAL
dti-1422	102	19	4.6 ± 0.6 ns	QUANTITY
dti-1422	102	20	105.6	CARDINAL
dti-1422	102	21	107.6 ± 3.8 ns	QUANTITY
dti-1422	102	22	9.0 ± 0.5 8.5 ±	MONEY
dti-1422	102	23	0.8	CARDINAL
dti-1422	102	24	3.7	CARDINAL
dti-1422	102	25	4.3 ± 1.3 ns	QUANTITY
dti-1422	102	26	0.05	CARDINAL
dti-1422	102	27	0.01	CARDINAL
dti-1422	103	1	hdl	ORG
dti-1422	106	1	linagliptin	PERSON
dti-1422	107	1	linagliptin	PERSON
dti-1422	111	1	linagliptin	PERSON
dti-1422	113	1	saitama medical center	ORG
dti-1422	113	2	jichi medical university	ORG
dti-1422	114	1	first department	ORG
dti-1422	114	2	saitama medical center	ORG
dti-1422	114	3	jichi medical university	ORG
dti-1422	115	1	4	CARDINAL
dti-1422	116	1	20	CARDINAL
dti-1422	118	1	0.05	CARDINAL
dti-1422	119	1	hdl	ORG
dti-1422	120	1	5	CARDINAL
dti-1422	121	1	annual	DATE
dti-1422	123	1	ueda et al	PERSON
dti-1422	123	2	18	CARDINAL
dti-1422	123	3	ki	PERSON
dti-1422	123	4	kh	PERSON
dti-1422	123	5	yk	PERSON
dti-1422	123	6	kt	PERSON
dti-1422	123	7	first	ORDINAL
dti-1422	124	1	ki	PERSON
dti-1422	124	2	kh	PERSON
dti-1422	124	3	yk	PERSON
dti-1422	124	4	kt	PERSON
dti-1422	125	1	ki	PERSON
dti-1422	125	2	kh	PERSON
dti-1422	125	3	yk	PERSON
dti-1422	125	4	kt	PERSON
dti-1422	127	1	1	CARDINAL
dti-1422	127	2	grassmann	ORG
dti-1422	127	3	moeller s	PERSON
dti-1422	127	4	brown g. esrd	PERSON
dti-1422	127	5	2004	DATE
dti-1422	129	1	2005;20(12):2587–2593	CARDINAL
dti-1422	130	1	2	CARDINAL
dti-1422	130	2	atkins rc	PERSON
dti-1422	132	1	2005	DATE
dti-1422	132	2	67(94):s14	CARDINAL
dti-1422	133	1	3	CARDINAL
dti-1422	133	2	molitch	PERSON
dti-1422	133	3	franz mj	PERSON
dti-1422	136	1	4	CARDINAL
dti-1422	136	2	preis sr	PERSON
dti-1422	136	3	hwang sj	PERSON
dti-1422	136	4	coady s	PERSON
dti-1422	136	5	framingham	GPE
dti-1422	136	6	1950 to 2005	DATE
dti-1422	138	1	2009;119(13):1728–1735	CARDINAL
dti-1422	138	2	5	CARDINAL
dti-1422	138	3	kishikawa h	GPE
dti-1422	138	4	araki e	GPE
dti-1422	139	1	japanese	NORP
dti-1422	139	2	6-year	DATE
dti-1422	140	1	clin pract	ORG
dti-1422	141	1	1995;28(2):103–117	CARDINAL
dti-1422	142	1	6	CARDINAL
dti-1422	142	2	2	CARDINAL
dti-1422	142	3	33	CARDINAL
dti-1422	143	1	uk	GPE
dti-1422	144	1	lancet	ORG
dti-1422	145	1	1998	DATE
dti-1422	145	2	352(9131):837–853	CARDINAL
dti-1422	146	1	7	CARDINAL
dti-1422	146	2	boussageon r	PERSON
dti-1422	146	3	bejan-angoulvant	PERSON
dti-1422	146	4	saadatian-elahi	NORP
dti-1422	146	5	2	CARDINAL
dti-1422	149	1	araki	PERSON
dti-1422	149	2	koya	GPE
dti-1422	149	3	2	CARDINAL
dti-1422	151	1	2007;56(6):1727–1730.	DATE
dti-1422	152	1	9	CARDINAL
dti-1422	152	2	2	CARDINAL
dti-1422	153	1	j. 2010;31(23):2888–2896	PERSON
dti-1422	154	1	10	CARDINAL
dti-1422	155	1	bergamo	FAC
dti-1422	156	1	control clin trials	ORG
dti-1422	157	1	2003	DATE
dti-1422	157	2	24(4):442–461	CARDINAL
dti-1422	157	3	11	CARDINAL
dti-1422	158	1	brenner bm	PERSON
dti-1422	158	2	cooper me	PERSON
dti-1422	158	3	2	CARDINAL
dti-1422	160	1	2001;345(12):861–869	CARDINAL
dti-1422	160	2	12	CARDINAL
dti-1422	161	1	chalmers j	PERSON
dti-1422	161	2	joshi r	PERSON
dti-1422	161	3	kengne ap	PERSON
dti-1422	162	1	macmahon s. blood	PERSON
dti-1422	165	1	13	CARDINAL
dti-1422	166	1	chahal h	PERSON
dti-1422	166	2	chowdhury ta	PERSON
dti-1422	167	1	gliptins	PERSON
dti-1422	169	1	2007;100(11):671–677	CARDINAL
dti-1422	170	1	14	DATE
dti-1422	171	1	ahren b. dpp-4	PERSON
dti-1422	172	1	clin endocrinol metab	PERSON
dti-1422	173	1	2007;21(4	DATE
dti-1422	174	1	517–533	CARDINAL
dti-1422	174	2	15	CARDINAL
dti-1422	174	3	holst jj.	PERSON
dti-1422	174	4	linagliptin	PERSON
dti-1422	174	5	2	CARDINAL
dti-1422	175	1	opin investig	PERSON
dti-1422	176	1	2010;19(1):133–140	CARDINAL
dti-1422	176	2	16	CARDINAL
dti-1422	178	1	2011;13(10):939–946.	DATE
dti-1422	179	1	17	CARDINAL
dti-1422	180	1	laakso m	PERSON
dti-1422	180	2	2	CARDINAL
dti-1422	180	3	52-week	DATE
dti-1422	183	1	18	CARDINAL
dti-1422	184	1	owens dr	PERSON
dti-1422	184	2	dugi ka	PERSON
dti-1422	184	3	woerle hj	PERSON
dti-1422	184	4	2	CARDINAL
dti-1422	184	5	24-week	DATE
dti-1422	185	1	med. 2011	DATE
dti-1422	185	2	28(11):1352–1361	CARDINAL
dti-1422	186	1	19	CARDINAL
dti-1422	186	2	meinicke t	GPE
dti-1422	186	3	jones r	PERSON
dti-1422	186	4	weber s	PERSON
dti-1422	186	5	von eynatten m	PERSON
dti-1422	186	6	woerle hj	PERSON
dti-1422	186	7	2	CARDINAL
dti-1422	188	1	2012;14(6):565–574	CARDINAL
dti-1422	188	2	20	CARDINAL
dti-1422	188	3	schernthaner g	PERSON
dti-1422	188	4	barnett	PERSON
dti-1422	188	5	3572	CARDINAL
dti-1422	188	6	2	CARDINAL
dti-1422	190	1	2012;14(5):470–478	CARDINAL
dti-1422	191	1	mcgill jb	PERSON
dti-1422	191	2	sloan l	ORG
dti-1422	191	3	newman	PERSON
dti-1422	192	1	2	CARDINAL
dti-1422	192	2	1-year	DATE
dti-1422	194	1	2013;36(2	CARDINAL
dti-1422	195	1	237–244	CARDINAL
dti-1422	196	1	22	CARDINAL
dti-1422	196	2	groop	ORG
dti-1422	196	3	woerle hj	PERSON
dti-1422	196	4	von eynatten m. linagliptin	PERSON
dti-1422	196	5	2	CARDINAL
dti-1422	198	1	2013;36(11): 3460–3468.	DATE
dti-1422	200	1	kamatani n	PERSON
dti-1422	200	2	sawai y	PERSON
dti-1422	200	3	kanayama h	PERSON
dti-1422	200	4	katada	GPE
dti-1422	200	5	itoh m.	PERSON
dti-1422	200	6	sitagliptin	GPE
dti-1422	202	1	2013;4(4):5	CARDINAL
dti-1422	203	1	24	CARDINAL
dti-1422	203	2	von websky k	PERSON
dti-1422	203	3	dpp-4	ORG
dti-1422	205	1	2012;36(1):119–130	CARDINAL
dti-1422	205	2	25	DATE
dti-1422	206	1	matsuo s	PERSON
dti-1422	206	2	imai e	PERSON
dti-1422	206	3	gfr	PRODUCT
dti-1422	206	4	japan	GPE
dti-1422	207	1	j kidney dis	PERSON
dti-1422	208	1	2009;53(6):982–992	CARDINAL
dti-1422	208	2	26	CARDINAL
dti-1422	208	3	del prato s	PERSON
dti-1422	208	4	barnett	PERSON
dti-1422	208	5	woerle hj	PERSON
dti-1422	208	6	dugi ka	PERSON
dti-1422	208	7	2	CARDINAL
dti-1422	210	1	2011;13(3):258–267	CARDINAL